Afinitor
/
Afinitor is an mTOR inhibitor indicated for the treatment of various cancers, including advanced renal cell carcinoma, neuroendocrine tumors, and breast cancer. It is administered as an oral tablet and is available by prescription only. Patients are advised that Afinitor may cause serious side effects, including lung infections and kidney problems, and should not be used in patients with severe hypersensitivity to everolimus or any of its components.
FAQs about Afinitor
What should I do if I miss a dose?
If you miss a dose of Afinitor, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed dose. This information is provided in the Patient Counseling Information section of the label.
Can I take Afinitor while pregnant or breastfeeding?
Afinitor is not recommended for use during pregnancy due to potential harm to the fetus. Women who are pregnant or planning to become pregnant should discuss the risks with their healthcare provider. It is advised that women do not breastfeed while taking Afinitor, as it may pass into breast milk and affect the nursing infant. This information is found in the Warnings and Precautions section of the label.
Can I stop taking Afinitor suddenly?
Patients are advised not to stop taking Afinitor suddenly without consulting their healthcare provider, as abrupt discontinuation may lead to worsening of the condition being treated. Follow your prescriber\
25
commonly-prescribed
medication.